简介:CLINICALMATERIALSThepatientwas7year-oldboy,bodyweight20kg.HewasadmittedonMay10th,2002becauseoffever,rashes,enlargedlymphnodes,conjunctivaeinjection,strawberrytongue,edemaanderythemaofthehandsandfeet.Laboratorydataasfollow:1.Prominentincreaseinwhitebloodcell(WBC)14.3-22.7×109.2.Anemia,hemoglobin(Hb)121→103g/L.
简介:无
简介:Radiationtherapyperformsanimportantfunctionincancertreatment.However,resistanceoftumorcellstoradiationtherapystillremainsaseriousconcern,sothestudyofradiosensitizershasemergedasapersistenthotspotinradiationoncology.Alongwiththerapidadvancementofnanotechnologyinrecentyears,thepotentialvalueofnanoparticlesasnovelradiosensitizershasbeendiscovered.Thisreviewsummarizesthelatestexperimentalfindingsbothinvitroandinvivoandattemptstohighlighttheunderlyingmechanismsofresponseinnanoparticleradiosensitization.
简介:Objective:TostudytheeffectofantisenseVEGFRNAonratC6gliomasinvivoandfindoutthefeasibilityofantiangiogenesistherapywithantisenseVEGFRNAformalignantgliomas.Methods:ParentalratC6gliomacellsandC6cellstransfectedwithantisenseVEGFcDNAwereimplantedintracerebrallyandsubcutaneouslyintoSDratsascontrolandtransfectedgroup.RatsbearingcerebralandsubcutaneousC6gliomasweretreatedwithantisenseVEGFcDNAastreatedgroupandsenseVEGFcDNAandemptyvectorascontroloftreatedgroup.Thegeneralmanifestation,survivaltime,MRIandhistopathologicalchangesofallratswereobserved.Thevolumeofsubcutaneouslyimplantedtumorswasdeterminedregularly.InsituhybridizationandimmunohistochemicalstainingwereusedfordetectionofVEGFgeneexpressionofgliomaswhilePCNAimmunostainingandTUNELmethodforexaminationofproliferationactivityandapoptosisofgliomas,respectively.Results:Thesurvivaloftheratsintransfectedandtreatedgroupwasprolonged.Thereweretworatssurvivingover90dinthetreatedgroupandtheirtumorsdisappeared.TheVEGFgeneexpression,thenumberofmicrovesselsandtheproliferationactivityweredecreasedandalargeamountofapoptoticcellscouldbefoundincerebralandsubcutaneousgliomasintreatedandtransfectedgroups.Conclusion:VEGFisoneofthecandidategenesforgenetherapyofmalignantgliomas.AntisenseVEGFRNAcombinedwithothertherapiesshouldbestudiedfurtherforenhancingthetherapeuticeffectofmalignantgliomas.
简介:Palliativecareisthereliefofsymptomswithoutdealingwiththeunderlyingcause,e.g.useofanalgesia,torelievepain.Theuseofsuchanagentalleviatesthesymptomswithoutcuringtheunderlyingdisease.Thisisthetypeofcareforpatientswithseriousillnesses.Itfocusesonimprovingqualityoflife,notjustinyourbody,butalsoinyourmindandspirit.Thereisathinlinebetweenpalliativecareandhospicecare.
简介:Melanomaisthedeadliestformofskincancerandhasanincidencethatisrisingfasterthananyothersolidtumor.Metastaticmelanomatreatmenthasconsiderablyprogressedinthepastfiveyearswiththeintroductionoftargetedtherapy(BRAFandMEKinhibitors)andimmunecheckpointblockade(anti-CTLA4,anti-PD-1,andanti-PD-L1).However,eachtreatmentmodalityhaslimitations.Treatmentwithtargetedtherapyhasbeenassociatedwithahighresponserate,butwithshort-termresponses.Conversely,treatmentwithimmunecheckpointblockadehasalowerresponserate,butwithlongtermresponses.Targetedtherapyaffectsantitumorimmunity,andsynergymayexistwhentargetedtherapyiscombinedwithimmunotherapy.Thisarticlepresentsabriefreviewoftherationaleandevidenceforthepotentialsynergybetweentargetedtherapyandimmunecheckpointblockade.Challengesanddirectionsforfuturestudiesarealsoproposed.
简介:Hormonereplacementtherapy(HRT)isinuseformorethanahalfofcentury,butthequestionofindicationsandidealcandidatesforHRTremainsunclear.Postmenopausalwomenareapopulationwiththeincreasingrisksforcardiovasculardiseaseswhicharethemaincauseofdeathinthisgroup.Declineinoestrogenconcentrations
简介:Platinum-basedanticanceragentsarewidelyusedasfirst-linedrugsincancerchemotherapyforvarioussolidtumors.However,greatsideeffectsandoccurrenceofresistanceremainasthemajordrawbacksforalmostalltheplatinumdrugsdeveloped.Toconquertheseproblems,newstrategiesshouldbeadoptedforplatinumdrugbasedchemotherapy.Modernnanotechnologyhasbeenwidelyemployedinthedeliveryofvarioustherapeuticsanddiagnostic.Itprovidesthepossibilityoftargeteddeliveryofacertainanticancerdrugtothetumorsite,whichcouldminimizetoxicityandoptimizethedrugefficacy.Here,inthisreview,wefocusedontherecentprogressinpolymerbaseddrugdeliverysystemsforplatinum-basedcombinationtherapy.
简介:
简介:Laryngealsquamouscellcarcinoma(LSCC)remainsahighlymorbidandfataldisease.Historically,ithasbeenamodelexamplefororganpreservationandtreatmentstratificationparadigms.Unfortunately,survivalforLSCChasstagnatedoverthepastfewdecades.Astheeraofnext-generationsequencingandpersonalizedtreatmentforcancerapproaches,LSCCmaybeanidealdiseaseforconsiderationoffurthertreatmentstratificationandpersonalization.Here,wewilldiscusstheimportanthistoryofLSCCasamodelsystemfororganpreservation,uniqueandpotentiallytargetablegeneticsignaturesofLSCC,andmethodsforbringingstratified,personalizedtreatmentstrategiestothe21~(st)century.
简介:Usingofactivecardiacmedicaldevicesincreasessteadily.InEurope,therewere183implantsofICDand944implantsofPM,119ofbiventricularICDand41ofbiventricularPM,allpermillionin-habitantsin2014.Healthcareenvironments,includingradiotherapytreatmentrooms,areconsideredchallengingfortheseimplantabledevices.Exposuretoradiationmaycausethedevicetoexperienceprematureelectivereplacementindicator,decreasedpacingamplitudeorpacinginhibition,inappropri-ateshocksorinhibitionoftachyarrhythmiatherapyandlossofdevicefunction.
简介:NatsumeSōseki(1867-1916)sufferedfromcyclicmentaldepressionsthroughhislife,anditwaswhenhewasinthestateofthemostterribleonethathestartedhiscareerasawriterbywritingIAmaCat(1905-1906).TherearesomeevidencebyhiswifeandfriendsthatSōseki’sconditionofdiseasedramaticallyimprovedduringitsserializationonamagazine,andthewriterhimselfadmitedhumorouslyintheprefaceofotherworkthatitwashisdepressionandmaniathatenabledhimtoproduceIAmaCatandotherearlyworks.Thispaperaimsatdescribingtheprocesshowhisactofnarratinghadtherapeuticeffectsonhisstateofmindfocusingontheconstructionofcomplicitousrelationshipbetweenanimpliedauthorandreadersintheworkbytheuniquefunctionsofthefirst-‘person’narrator:ACat.Amongothers,IwillconsidertheinfluenceofLaurenceSterne’sTristramShandy(1759-1767),whichSōsekiintroducedtoJapanforthefirsttime,bydiscussingthefrequentuseofmetalepsisthatthetwoworkshaveincommon.
简介:Transcatheteraorticvalvereplacement(TAVR)isincreasinglyusedforthetreatmentofhighorveryhighsurgicalriskpatientswithsevereaorticstenosis(AS)orfailingsurgicalbioprosthesis(valve-in-valve,VIV-TAVR).InTAVR,thecollapsedtranscatheterheartvalve(THV)isintroducedusingthedeliverysysteminsertedfromthefemoralartery(preferred)orotheralternativeaccesses(transapical,transaortic,transcarotid,subclavian/transinnominateortranscaval).Thedeliverysystemisthenadvanceduntilcoaxiallyalignedwiththeaorticannulus,wheretheTHVisdeployed.Thisprocedurecanbeassociatedwithcomplicationssuchasaccesssiteinjury(vascularcomplication),paravalvarleak,cerebrovasculareventsandconductiondisturbances.However,therapidacceptanceandsuccessesobservedwithTAVRhavebeenmadepossiblethroughcarefulpatientselection,preproceduralplanning(i.e.MDCTannularsizing),THVtechnology(i.e.newgenerationvalves),andproceduraltechniques(i.e.minimalistTF-TAVRandalternativepercutaneousaccessoptions),aswellasadecreaseincomplicationsasTAVRexperiencegrows.ThoughtheresultsorongoingclinicaltrialsevaluatingTAVRinintermediatesurgicalriskpatientsarepending,itislikelythatTAVRwillsoonbeapprovedforlowerriskpatientsaswell.